Volume 37, No. 10, page 5887 (only in the printed version): Left column, text lines 7 to 10 should read:
Fifty-eight patients showed CR or PR to pre-nivolumab treatment; patients pretreated with bevacizumab before nivolumab showed a significantly higher ORR (38%) than those pretreated without bevacizumab (8.9%) (p=0.02).
- Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved